Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
J Cutan Pathol ; 36(6): 660-7, 2009 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-19515045

RESUMO

BACKGROUND: Neonatal lupus erythematosus (NLE) is a disease associated with the transplacental transfer of maternal anti-Ro/SSA. The histopathologic characteristics of neonatal lupus have been described as compatible with cutaneous lupus based on isolated cases. METHODS: We retrospectively review the available literature and compare them with findings obtained in seven biopsies of five cases. RESULTS: Erythematous-desquamative lesions and urticaria-like lesions were observed in our series. Two cases showed both type of lesions. Vacuolar alterations at the dermoepidermal interface and adnexal structures were the histopathologic findings on erythematous-desquamative lesions, and a superficial and deep perivascular and periadnexal lymphocytic infiltrate was the major pattern in urticaria-like lesions. One case showed prevalence of eosinophils in the inflammatory infiltrate. Sixty cases have been reported previously. Sixty-five percent presented erythematous-desquamative and 29% urticaria-like lesions. Pathologic findings of erythematous-desquamative lesions were similar to those found in our series, but epidermal vacuolar changes were the predominant histopathologic finding in urticaria-like lesions of cases reported in the literature. CONCLUSIONS: The majority of cases of NLE show vacuolar alteration at the dermoepidermal interface and adnexal structures. Some cases exhibit a superficial and deep perivascular and periadnexal lymphocytic infiltrate without epidermal alteration, and rare cases may have eosinophils in the infiltrate.


Assuntos
Lúpus Eritematoso Cutâneo/patologia , Feminino , Humanos , Imuno-Histoquímica , Lactente , Recém-Nascido , Doenças do Recém-Nascido/patologia , Lúpus Eritematoso Cutâneo/metabolismo , Masculino , Estudos Retrospectivos
2.
Nefrologia ; 21(1): 52-8, 2001.
Artigo em Espanhol | MEDLINE | ID: mdl-11344962

RESUMO

Hypertensive mechanisms are postulated to play a major role in the progressive glomerulosclerosis (GS) after renal mass reduction. Previous studies have demonstrated differences in the progression to glomerulosclerosis with the use of different antihypertensive drugs. We analyzed whether the use of carvedilol (CVD), a new beta-adrenoceptor antagonist and vasodilator slows the progression of glomerulosclerosis in 5/6 nephrectomised (Nx) rats. Fifty-four adult Sprague-Dawley rats were distributed among five groups, four with 5/6 Nx, vehicle treated and CVD at 5, 10 and 20 mg/kg/day and sham (no renal ablation or drug treatment). Tailcuff blood pressure, serum creatinine and urine protein concentration were measured. At the end of the experiment remnant kidney was removed for morphometric studies. Rats treated with 10 and 20 mg/kg/day of CVD showed controlled systemic blood pressure. Serum creatinine was similar in all treated groups with CVD, and half the levels observed in the vehicle-treated rats. The prevalence of glomerular lesions was closely associated with the degree of proteinuria. Eleven weeks after 5/6 Nx, vehicle-treated rats exhibited marked GS with 76% of affected glomeruli and creatinine retention. By contrast, renal injury was largely prevent in those rats treated with 10 and 20 mg/kg/day of CVD. Tuft enlargement occurred in all groups but was more prominent in vehicle-treated group, 1.5 times higher than the group treated with 20 mg/kg/day of CVD. Although, these data demonstrate the importance of systemic blood pressure control in the renal protective efficacy of carvedilol, other less-known mechanisms of this drug must be investigated.


Assuntos
Anti-Hipertensivos/uso terapêutico , Carbazóis/uso terapêutico , Falência Renal Crônica/tratamento farmacológico , Propanolaminas/uso terapêutico , Animais , Carvedilol , Relação Dose-Resposta a Droga , Masculino , Ratos , Ratos Sprague-Dawley
3.
Electrophoresis ; 20(14): 2801-9, 1999 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-10546810

RESUMO

The separation of protein by continuous-flow electrophoresis is disturbed by a number of effects which cause spreading of the protein streams with a loss of resolution. Two numerical models have been used to describe the coupling between the various spreading phenomena. A simple model takes into account molecular diffusion, electroosmosis and residence time gradients; the main model differs from the simple one by taking account of electrohydrodynamics. The influence of the separation chamber thickness, the radius of the sample filament, the field strength, and the residence time is explored. The simulations show that each dispersive effect has its own range of predominance, so that an optimum is found for the thickness of the separation chamber.


Assuntos
Eletroforese/instrumentação , Eletroforese/métodos , Proteínas/química , Animais , Humanos
5.
Radiother Oncol ; 49(2): 163-7, 1998 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10052882

RESUMO

PURPOSE: To assess whether tumour proliferation as measured by Ki67 immunostaining has any predictive value for local control in bladder cancer patients treated by radiotherapy. PATIENTS AND METHODS: Fifty-five patients suffering from infiltrating bladder carcinoma recommended for radical radiotherapy (66 Gy/6-7 weeks) were included in this study. Paraffin-embedded pre-treatment tumour sections were stained with the Ki67 antibody. The percentage of Ki67-positive nuclei was correlated with established prognostic factors, local control and survival. RESULTS: The Ki67 index was not related to local control in our patients when the median was selected as the cut-off value. Patients with tumours with a very low (<27%) Ki67 index had better local control at 5 years (69%) than patients with tumours with greater (>27%) Ki67 expression indices (31.5%) (P<0.05; log-rank test). CONCLUSIONS: Ki67 immunostaining was a feasible method to estimate tumour proliferation. Patients with very low proliferating tumours seemed to achieve better local control after fractionated radiotherapy compared to other patients. Further studies are needed with a greater number of patients to accurately define the role of Ki67 expression in predicting tumour repopulation during fractionated radiotherapy.


Assuntos
Carcinoma de Células de Transição/radioterapia , Antígeno Ki-67/sangue , Neoplasias da Bexiga Urinária/radioterapia , Biomarcadores Tumorais/sangue , Carcinoma de Células de Transição/sangue , Carcinoma de Células de Transição/mortalidade , Carcinoma de Células de Transição/patologia , Divisão Celular/efeitos da radiação , Seguimentos , Humanos , Antígeno Ki-67/biossíntese , Variações Dependentes do Observador , Prognóstico , Estudos Retrospectivos , Taxa de Sobrevida , Neoplasias da Bexiga Urinária/sangue , Neoplasias da Bexiga Urinária/mortalidade , Neoplasias da Bexiga Urinária/patologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA